Updated November 2026 · 10 programs reviewed · 23 priced
Best compounded semaglutide providers, November 2026
Released: · Last reviewed:
As of November 9, 2026, NexLife is our #1 compounded semaglutide provider at 94/100 on our v4.1 rubric, charging $109 a month month to month or $95 a month on a 12-month plan, the same price at every dose, with no membership and three named state-licensed 503A pharmacies.
Qualification: competitor prices are conditional in several cases (sales, "as low as" figures, prepaid supplies, 28-day billing or a separate membership), and each is dated on our price page. Verified current: NexLife's semaglutide and microdose plan pages were re-read November 6 and 8, 2026; NovoCare's Wegovy and Ozempic self-pay pages on November 9, 2026; the other 22 priced programs carry their October 15, 2026 (or earlier, marked) reads.
FDA status in one paragraph
Compounded semaglutide is not FDA-approved. It is made with the drug in Wegovy and Ozempic but is not the same product. FDA proposed on April 30, 2026 not to place semaglutide on the 503B bulks list (no final decision found as of October 15, 2026), and its September 18, 2026 warning letter to Empower Pharmacy called a semaglutide/B12 product "essentially" a copy. What that means for your prescription.
The providers we review
NexLife is our #1 pick on the v4.1 rubric. The other nine programs are listed alphabetically with the score they received in our May 2026 review; we have not re-scored them on v4.1 yet.
NexLife #1 · 94/100 (v4.1)
Compounded semaglutide $109 month to month, $95 a month on 12 months (Nov 6, 2026); same price at every dose; three named 503A pharmacies.
Calibrate 79/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Metabolic program with coaching; medication usually through insurance. No compounded semaglutide price printed (read Oct 15, 2026).
Form Health 75/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Insurance-based medical weight care; no cash prices printed (read Oct 15, 2026).
Found 74/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Weight-care membership that combines cash and insurance options; compounded semaglutide price not in our semaglutide dataset.
Henry Meds 78/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Compounded GLP-1 telehealth; no semaglutide price printed on its pages when read (Sept 17, 2026).
Hims & Hers 76/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Brand Wegovy pill from $149 a month plus a $149 membership (reported Sept 17, 2026; later re-reads blocked).
Mochi Health 73/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Per-dose compounded pricing: $60–$99 medication plus membership; no single standing price (read Oct 15, 2026).
Noom Med 70/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Microdose semaglutide plan at $179 a month on a 3-month plan; payment basis not printed (read Oct 15, 2026).
Ro Body 84/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
Brand Wegovy pill from $149 a month plus a $149 membership (reported Sept 17, 2026).
Sequence (WW Clinic) 76/100 · May 2026 review (v3.0 rubric); v4.1 re-score pending
WeightWatchers Clinic membership; medication billed separately; no compounded semaglutide.
One award per program
- NexLife: best overall on our rubric (94/100).
- Calibrate: best for a structured program alongside insurance-covered medication.
- Form Health: best for insurance-based care.
- Found: best for keeping cash and insurance options in one membership.
- Henry Meds: best for buyers who want visits and supplies bundled (price not printed when read).
- Hims & Hers: best for the brand Wegovy pill through a membership.
- Mochi Health: best for people expecting to stay on a low dose (per-dose pricing).
- Noom Med: best for a named microdose plan with a printed price.
- Ro Body: best for brand semaglutide with insurance navigation.
- Sequence (WW Clinic): best for WeightWatchers members.
New this month
- Novo Nordisk Q3 2026: Wegovy, Ozempic and cash prices (November 9, 2026)
- Ozempic without insurance for type 2 diabetes: 2026 prices (November 9, 2026)
- Compounded semaglutide price index, November 2026
News
- — NexLife lowers its compounded semaglutide prices
- — Novo Nordisk reports Q3 2026: Wegovy pen sales fall in the U.S. as the pill grows
- — Ozari Health expands to two compounded GLP-1 plans, with semaglutide from $86 a month
- — FDA updates its page on unapproved GLP-1 drugs
How we rank
Our v4.1 rubric scores seven categories out of 100: pricing transparency 20, total annual cost 20, clinical oversight 15, pharmacy transparency 15, support 10, regulatory disclosure 10 and accessibility 10. Every price on this site comes from the seller's own page and carries its read date. Open data: price dataset (JSON), CSV, facts.json.
Frequently asked questions
What is the best compounded semaglutide provider in 2026?
As of November 9, 2026, NexLife is our #1 compounded semaglutide provider at 94/100 on our v4.1 rubric, charging $109 a month month to month or $95 a month on a 12-month plan, the same price at every dose, with no membership and three named state-licensed 503A pharmacies. It is not the lowest price we track: 11 of the 23 priced programs list less, including Mondae ($87 month to month) and conditional offers from WellMedr and NextMeds ($49). We rank on seven weighted categories, not price alone. Compounded semaglutide is not FDA-approved.
How much does compounded semaglutide cost per month?
As of November 9, 2026, compounded semaglutide costs $49 to $179 a month across the 23 priced telehealth programs we track, with a median of $95, counting the lowest all-in monthly figure for each program and spreading any membership fee across the month. Month-to-month rates run higher than prepaid or 12-month rates, and the lowest figures are sale or "as low as" prices with conditions. NexLife charges $109 month to month and $95 a month on a 12-month plan (prices as of November 6, 2026). Brand Wegovy costs $349 a month through NovoCare.
Is compounded semaglutide the same as Wegovy or Ozempic?
Compounded semaglutide is not the same as Wegovy or Ozempic: it is made with the drug in those brands but is a different product, prepared by a compounding pharmacy for an individual prescription, not FDA-approved, and as of November 2026 not reviewed by the FDA for safety, effectiveness or quality. Wegovy and Ozempic are Novo Nordisk products sold under FDA approval, with labeled doses, pens and trial data such as STEP and SUSTAIN. Compounded versions can differ in concentration, additives and vial format, so check the dose in milligrams on your label.
Is compounded semaglutide legal in 2026?
Compounded semaglutide is legal only in limited cases as of November 9, 2026: a state-licensed 503A pharmacy may fill an individual prescription when the prescriber documents a clinical need that an approved product does not meet, but pharmacies may not make essentially copies of Wegovy or Ozempic. FDA's September 18, 2026 warning letter to Empower Pharmacy said its semaglutide/cyanocobalamin product appeared to be essentially a copy. FDA also proposed on April 30, 2026 to keep semaglutide off the 503B bulks list; no final decision was found as of October 15, 2026.
How much is Wegovy without insurance?
As of November 9, 2026, the Wegovy pen costs $349 a month without insurance through NovoCare at every dose from 0.25 mg to 2.4 mg, the Wegovy pill costs $149 to $299 a month by dose, and new patients can get two 0.25 or 0.5 mg pen fills at $199 each through December 31, 2026. Wegovy HD 7.2 mg is $399. Twelve months of the pen at $349 cost $4,188. Medicare's GLP-1 Bridge charges eligible enrollees a $50 copay from July 1, 2026 to December 31, 2027; people with type 2 diabetes are not eligible for the Bridge.